Original Research
Published on 18 Aug 2023
ErbB2 (HER2)-CAR-NK-92 cells for enhanced immunotherapy of metastatic fusion-driven alveolar rhabdomyosarcoma
in Cancer Immunity and Immunotherapy
- 7,044 views
- 14 citations
Original Research
Published on 18 Aug 2023
in Cancer Immunity and Immunotherapy
Review
Published on 18 Aug 2023
in Cancer Immunity and Immunotherapy
Original Research
Published on 18 Aug 2023
in Cancer Immunity and Immunotherapy
Original Research
Published on 18 Aug 2023
in Cancer Immunity and Immunotherapy
Original Research
Published on 18 Aug 2023
in Cancer Immunity and Immunotherapy
Original Research
Published on 17 Aug 2023
in Cancer Immunity and Immunotherapy
Original Research
Published on 17 Aug 2023
in Cancer Immunity and Immunotherapy
Original Research
Published on 17 Aug 2023
in Cancer Immunity and Immunotherapy
Original Research
Published on 17 Aug 2023
in Cancer Immunity and Immunotherapy
Review
Published on 17 Aug 2023
in Cancer Immunity and Immunotherapy
Original Research
Published on 17 Aug 2023
in Cancer Immunity and Immunotherapy
Review
Published on 16 Aug 2023
in Cancer Immunity and Immunotherapy
Correction
Published on 16 Aug 2023
in Cancer Immunity and Immunotherapy
Review
Published on 16 Aug 2023
in Cancer Immunity and Immunotherapy
Case Report
Published on 15 Aug 2023
in Cancer Immunity and Immunotherapy
Editorial
Published on 15 Aug 2023
in Cancer Immunity and Immunotherapy